JP2002505323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002505323A5 JP2002505323A5 JP2000534538A JP2000534538A JP2002505323A5 JP 2002505323 A5 JP2002505323 A5 JP 2002505323A5 JP 2000534538 A JP2000534538 A JP 2000534538A JP 2000534538 A JP2000534538 A JP 2000534538A JP 2002505323 A5 JP2002505323 A5 JP 2002505323A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- treatment
- compound according
- compound
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 206010020583 Hypercalcaemia Diseases 0.000 claims 1
- 208000002780 Macular Degeneration Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010027476 Metastasis Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000000148 hypercalcaemia Effects 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 230000003211 malignant Effects 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000015590 smooth muscle cell migration Effects 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
Claims (6)
- 治療に有効な量の請求項1、2又は3記載の化合物と薬剤学的に許容し得るキャリアとからなる製薬組成物。
- 治療の必要としている哺乳類におけるαvβ3 インテグリンにより媒介された状態の治療用の薬剤の調製のための、請求項1、2又は3記載の化合物の使用。
- 腫瘍転移、固体腫瘍成長、血管形成、オステオポローシス、悪性の体液過カルシウム血症、平滑筋細胞移動、リウマチ様関節炎、及び黄斑変性から選択された少なくとも一つの状態の治療用の薬剤の調製のための、請求項1、2又は3記載の化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3427098A | 1998-03-04 | 1998-03-04 | |
US09/034,270 | 1998-03-04 | ||
PCT/US1999/003281 WO1999044994A1 (en) | 1998-03-04 | 1999-02-22 | Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002505323A JP2002505323A (ja) | 2002-02-19 |
JP2002505323A5 true JP2002505323A5 (ja) | 2005-08-18 |
Family
ID=21875345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000534538A Pending JP2002505323A (ja) | 1998-03-04 | 1999-02-22 | インテグリンアンタゴニストであるメタ‐アザサイクリックアミノ安息香酸化合物類及びその誘導体 |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1060164A1 (ja) |
JP (1) | JP2002505323A (ja) |
KR (1) | KR20010041584A (ja) |
CN (1) | CN1214011C (ja) |
AP (1) | AP1244A (ja) |
AR (1) | AR018139A1 (ja) |
AU (1) | AU753230B2 (ja) |
BG (1) | BG104740A (ja) |
BR (1) | BR9908470A (ja) |
CA (1) | CA2322207A1 (ja) |
EA (1) | EA200000804A1 (ja) |
EE (1) | EE200000506A (ja) |
GE (1) | GEP20033118B (ja) |
HR (1) | HRP20000574A2 (ja) |
HU (1) | HUP0100865A3 (ja) |
ID (1) | ID25591A (ja) |
IL (1) | IL137653A0 (ja) |
IS (1) | IS5582A (ja) |
MY (1) | MY123908A (ja) |
NO (1) | NO315703B1 (ja) |
NZ (1) | NZ506598A (ja) |
OA (1) | OA11530A (ja) |
PL (1) | PL342726A1 (ja) |
SK (1) | SK13002000A3 (ja) |
TR (1) | TR200002542T2 (ja) |
UA (1) | UA71906C2 (ja) |
WO (1) | WO1999044994A1 (ja) |
YU (1) | YU52000A (ja) |
ZA (1) | ZA994406B (ja) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
WO2001079173A2 (en) | 2000-04-17 | 2001-10-25 | Celltech R & D Limited | Enamine derivatives as cell adhesion molecules |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6921767B2 (en) * | 2000-06-15 | 2005-07-26 | Pharmacia Corporation | Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives |
EP1305291A1 (en) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
EP1572210A1 (en) * | 2002-12-20 | 2005-09-14 | Pharmacia Corporation | The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
CA2612979A1 (en) * | 2005-06-10 | 2006-12-21 | Bipar Sciences, Inc. | Parp modulators and treatment of cancer |
CN101687040A (zh) | 2007-03-01 | 2010-03-31 | 马林克罗特公司 | 整合光活性的小分子及其用途 |
JP4792124B1 (ja) * | 2010-11-15 | 2011-10-12 | エフイートレード株式会社 | 車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法 |
MX2015000794A (es) | 2012-07-18 | 2015-10-12 | Univ Saint Louis | Derivados de aminoácido beta como antagonistas de integrina. |
US8716226B2 (en) | 2012-07-18 | 2014-05-06 | Saint Louis University | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
WO2015181676A1 (en) | 2014-05-30 | 2015-12-03 | Pfizer Inc. | Carbonitrile derivatives as selective androgen receptor modulators |
CN112299983B (zh) * | 2014-06-04 | 2024-05-17 | 孟山都技术公司 | 3,6-二氯水杨酸化合物以及相关合成方法 |
CN108779077A (zh) | 2015-12-30 | 2018-11-09 | 圣路易斯大学 | 作为pan整合素拮抗剂的间位氮杂环氨基苯甲酸衍生物 |
US20230192661A1 (en) | 2020-05-14 | 2023-06-22 | Ube Corporation | 1, 4, 5, 6-tetrahydropyrimidine-2-amine derivative |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
WO2023085396A1 (ja) | 2021-11-12 | 2023-05-19 | Ube株式会社 | アルポート症候群を治療または予防するための医薬組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1085980C (zh) * | 1995-08-30 | 2002-06-05 | G·D·瑟尔公司 | 间-胍基、脲基、硫脲基或氮杂环氨基苯甲酸衍生物用作整合素拮抗剂 |
-
1999
- 1999-02-11 ZA ZA9904406A patent/ZA994406B/xx unknown
- 1999-02-22 TR TR2000/02542T patent/TR200002542T2/xx unknown
- 1999-02-22 WO PCT/US1999/003281 patent/WO1999044994A1/en not_active Application Discontinuation
- 1999-02-22 PL PL99342726A patent/PL342726A1/xx unknown
- 1999-02-22 YU YU52000A patent/YU52000A/sh unknown
- 1999-02-22 IL IL13765399A patent/IL137653A0/xx unknown
- 1999-02-22 JP JP2000534538A patent/JP2002505323A/ja active Pending
- 1999-02-22 EA EA200000804A patent/EA200000804A1/ru unknown
- 1999-02-22 EE EEP200000506A patent/EE200000506A/xx unknown
- 1999-02-22 OA OA1200000238A patent/OA11530A/en unknown
- 1999-02-22 NZ NZ506598A patent/NZ506598A/en unknown
- 1999-02-22 AP APAP/P/2000/001893A patent/AP1244A/en active
- 1999-02-22 BR BR9908470-8A patent/BR9908470A/pt not_active Application Discontinuation
- 1999-02-22 SK SK1300-2000A patent/SK13002000A3/sk unknown
- 1999-02-22 CA CA002322207A patent/CA2322207A1/en not_active Abandoned
- 1999-02-22 AU AU32947/99A patent/AU753230B2/en not_active Ceased
- 1999-02-22 KR KR1020007009774A patent/KR20010041584A/ko not_active Application Discontinuation
- 1999-02-22 CN CNB998035815A patent/CN1214011C/zh not_active Expired - Fee Related
- 1999-02-22 HU HU0100865A patent/HUP0100865A3/hu unknown
- 1999-02-22 UA UA2000095148A patent/UA71906C2/uk unknown
- 1999-02-22 ID IDW20001695A patent/ID25591A/id unknown
- 1999-02-22 GE GEAP19995537A patent/GEP20033118B/en unknown
- 1999-02-22 EP EP99937927A patent/EP1060164A1/en active Pending
- 1999-03-02 AR ARP990100880A patent/AR018139A1/es unknown
- 1999-03-03 MY MYPI99000772A patent/MY123908A/en unknown
-
2000
- 2000-08-04 IS IS5582A patent/IS5582A/is unknown
- 2000-08-30 NO NO20004316A patent/NO315703B1/no not_active IP Right Cessation
- 2000-09-01 BG BG104740A patent/BG104740A/xx unknown
- 2000-09-01 HR HR20000574A patent/HRP20000574A2/hr not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002505323A5 (ja) | ||
JP2005511592A5 (ja) | ||
JP2009536660A5 (ja) | ||
JP2007501281A5 (ja) | ||
JP2002533472A5 (ja) | ||
JP2004531544A5 (ja) | ||
JP2001526218A5 (ja) | ||
RU2000132188A (ru) | Производные эпотилонов, их синтез и применение | |
JP2002543185A5 (ja) | ||
JP2003509349A5 (ja) | ||
JP2009504748A5 (ja) | ||
JP2002539159A5 (ja) | ||
JP2002539156A5 (ja) | ||
RU96119781A (ru) | Применение 2-фенил-3-ароилбензотиофенов для снижения уровня холестерина в сыворотке, фармацевтическая композиция | |
JP2013508279A5 (ja) | ||
JP2006182786A5 (ja) | ||
JP2006507265A5 (ja) | ||
EP2036902A3 (en) | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | |
JP2005511697A5 (ja) | ||
JP2003522198A5 (ja) | ||
KR960037675A (ko) | 벤조니트릴 및 벤조플루오라이드 | |
JP2002525323A5 (ja) | ||
EP0992509A3 (en) | Novel macrolide derivatives | |
JP2002543114A5 (ja) | ||
JP2002525330A5 (ja) |